Orange Book product · Brand (NDA)
ZINC SULFATE
ZINC SULFATE
At a glance
May 05, 1987
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 05, 1987
39 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
ZINC SULFATE
Strength
EQ 1MG ZINC/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
NDA 019229
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2020ZINC SULFATEBrand (NDA)
NDA 209377 · AM REGENT
- 2025ZINC SULFATEGeneric (ANDA)
ANDA 217624 · STIRA
- 2025ZINC SULFATEGeneric (ANDA)
ANDA 219585 · ASPIRO
- 2024ZINC SULFATEGeneric (ANDA)
ANDA 218059 · APOTEX
- 2024ZINC SULFATEGeneric (ANDA)
ANDA 216135 · SOMERSET THERAPS LLC
- 2024ZINC SULFATEGeneric (ANDA)
ANDA 214597 · NIVAGEN PHARMS INC
- 2023ZINC SULFATEGeneric (ANDA)
ANDA 216249 · GLAND
- 2023ZINC SULFATEGeneric (ANDA)
ANDA 217074 · ZYDUS PHARMS
- 2022ZINC SULFATEGeneric (ANDA)
ANDA 216145 · FRESENIUS KABI USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
